Myhr KM - Search Results

1

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O. Kampman MT, et al. Among authors: myhr km. J Neurol. 2013 Jun;260(6):1481-8. doi: 10.1007/s00415-012-6814-x. Epub 2013 Jan 6. J Neurol. 2013. PMID: 23292231

2

Absence of HTLV-1 related sequences in MS from high prevalence areas in western Norway.

Myhr KM, Frost P, Grønning M, Midgard R, Kalland KH, Helland DE, Nyland HI. Myhr KM, et al. Acta Neurol Scand. 1994 Jan;89(1):65-8. doi: 10.1111/j.1600-0404.1994.tb01634.x. Acta Neurol Scand. 1994. PMID: 8178631

3

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H. Myhr KM, et al. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):539-42. doi: 10.1136/jnnp.64.4.539. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576551 Free PMC article.

4

Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

Myhr KM, Riise T, Green Lilleås FE, Beiske TG, Celius EG, Edland A, Jensen D, Larsen JP, Nilsen R, Nortvedt MW, Smievoll AI, Vedeler C, Nyland HI. Myhr KM, et al. Neurology. 1999 Mar 23;52(5):1049-56. doi: 10.1212/wnl.52.5.1049. Neurology. 1999. PMID: 10102427 Clinical Trial.

5

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

Nortvedt MW, Riise T, Myhr KM, Nyland HI. Nortvedt MW, et al. Among authors: myhr km. Neurology. 1999 Sep 22;53(5):1098-103. doi: 10.1212/wnl.53.5.1098. Neurology. 1999. PMID: 10496273

6

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.

Myhr KM, Riise T, Vedeler C, Nortvedt MW, Grønning R, Midgard R, Nyland HI. Myhr KM, et al. Mult Scler. 2001 Feb;7(1):59-65. doi: 10.1177/135245850100700110. Mult Scler. 2001. PMID: 11321195

7

The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis.

Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A. Dai KZ, et al. Among authors: myhr km. Genes Immun. 2001 Aug;2(5):263-8. doi: 10.1038/sj.gene.6363774. Genes Immun. 2001. PMID: 11528519

8

Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.

Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA. Myhr KM, et al. J Neurol Sci. 2002 Oct 15;202(1-2):93-7. doi: 10.1016/s0022-510x(02)00246-0. J Neurol Sci. 2002. PMID: 12220699

9

[New diagnostic criteria in multiple sclerosis].

Midgard R, Beiske AG, Celius EG, Jensen D, Hovdal H, Mellgren SI, Myhr KM. Midgard R, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 2003 May 15;123(10):1345-8. Tidsskr Nor Laegeforen. 2003. PMID: 12806674 Review. Norwegian. No abstract available.

10

Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients.

Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A. Harbo HF, et al. Among authors: myhr km. J Neuroimmunol. 2003 Oct;143(1-2):101-6. doi: 10.1016/j.jneuroim.2003.08.021. J Neuroimmunol. 2003. PMID: 14575924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page